Instituto Do Cancer Do Estado de Sao Paulo Octavio Frias de Oliveira

Rio de Janeiro 20941-150

0 studies enrolling now · 1 studies all time

What they study most

Advanced or Metastatic Solid Tumors

Studies at this site

• A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors — Completed